 |
|
|
| Home -> Products & Services -> Human Leukocyte Antigen (HLA) Expression Plasmid Vectors | ||
| Quick Inquiry |
Human Leukocyte Antigen (HLA) Expression Plasmid Vectors The Human Leukocyte Antigen (HLA) system is the name of the major histocompatibility complex (MHC) in humans. HLA is a group of highly polymorphic genetic loci and their encoded protein products, which are expressed on the surface of nearly all nucleated cells. HLA is critical for activating the appropriate immune response - either targeting infected or abnormal cells for destruction or tolerating self-antigens to prevent autoimmunity. Leveraging deep expertise in immunogenetics and molecular biology, RGBiotech offers a comprehensive portfolio of high-quality HLA expression plasmid vectors to support your research needs. Our plasmid vectors cover a wide range of HLA Class I (A, B, C) and Class II (DR, DQ, DP) alleles, including common and rare variants. These plasmid vectors enable efficient expression of specific HLA alleles in various mammalian cell lines. Product List for HLA Genomic Plasmid Vectors
Product List for HLA Protein Expression Plasmid Vectors
For inquiries about our HLA expression plasmids, customization options, or technical support, please contact our sales and support team at admin@rgbiotech.com. We are committed to providing the tools and expertise to accelerate your immunological research. Why Choose RGBiotech? 1) Extensive Allele Coverage: We offer one of the largest collections of HLA expression plasmids, including wild-type, mutant, and chimeric alleles, to accommodate diverse research applications.2) Expertise & Accuracy: Our team comprises immunologists and molecular biologists with decades of experience in HLA research, ensuring plasmids are designed for optimal expression and function. Our plasmid vectors are meticulously verified, ensuring the sequence accuracy of each HLA allele. 3) Customization Capabilities: We offer tailored plasmid design, including site-directed mutagenesis, fusion with reporter genes (e.g., GFP, FLAG), and vector optimization for specific cell types (e.g., mammalian, insect cells). 4) Fast Turnaround and Support: We provide rapid plasmid production and delivery, paired with dedicated technical support to assist with experimental design and troubleshooting. Product Features 1) Purified and Ready-to-Transfect Quality: Upon request, plasmid DNA can be prepared using endotoxin-free protocols, minimizing cytotoxicity and ensuring compatibility with sensitive cell-based assays.2) Sequence Verification: Each HLA insert undergoes full-length sequencing to confirm allele identity and the absence of mutations, guaranteeing genetic accuracy. 3) Versatile Vector Backbones: Available in multiple vector types, including transient expression vectors, lentiviral vectors for stable cell line generation, and baculoviral vectors for insect cell expression. 4) Selectable Markers: Vectors contain standard antibiotic resistance markers (e.g., Ampicillin, Kanamycin) for bacterial selection and often markers for mammalian cell selection (e.g., Neomycin/Puromycin). 5) Tag Options: Many constructs are available with optional epitope tags (e.g., FLAG, HA, GFP) for easy detection, purification, and visualization. 6) High Expression Efficiency: Plasmids are engineered with strong promoters (e.g., CMV, EF1α) and optimized Kozak sequences to ensure robust HLA protein expression in target cells. Product Applications Our HLA expression plasmids are widely used in cutting-edge immunological research and biotechnological development:1) Antigen Presentation Studies: Reconstituting HLA-peptide complexes in vitro to investigate T cell recognition, peptide binding affinity, and MHC restriction. 2) T Cell Therapy Development: Engineering antigen-presenting cells (APCs) or artificial antigen-presenting cells (aAPCs) with specific HLA alleles to activate and expand antigen-specific T cells for adoptive cell therapy. 3) Diagnostic Assay Development: Producing soluble HLA molecules for use in immunoassays (e.g., ELISA, flow cytometry) to detect HLA antibodies or measure peptide-HLA binding. 4) Structural Biology Research: Expressing HLA molecules for X-ray crystallography or cryo-electron microscopy to study their 3D structure and interactions with peptides, T cell receptors (TCRs), or antibodies. 5) Transplantation Immunology Research: Modeling HLA mismatches in vitro to study alloimmune responses and test immunosuppressive therapies. Read More HLA Introduction The Human Leukocyte Antigen (HLA) complex is a critical component of the vertebrate immune system. HLA is the human equivalent of the Major Histocompatibility Complex (MHC) in other vertebrates, constitutes a cluster of genes located on chromosome 6. HLA molecules present on the surface of most cells and are essential for the immune system to distinguish the body's own proteins from proteins made by foreign invaders such as viruses and bacteria. HLA proteins function as antigen-presenting molecules, binding to peptide fragments derived from intracellular (endogenous) or extracellular (exogenous) sources and displaying them to T cells. By presenting peptide antigens to T lymphocytes, HLA molecules initiate and regulate adaptive immune responses, making them fundamental to processes such as pathogen clearance, tumor surveillance, and transplant rejection. The study of HLA is fundamental to immunology, transplantation medicine, vaccine development, and understanding autoimmune diseases.HLA Classification HLA molecules are primarily classified into three major classes based on their structure, expression pattern, and biological function:1) Class I HLA Molecules (HLA-A, HLA-B, HLA-C): Encoded by HLA-A, -B, and -C loci, these molecules are expressed on the surface of nearly all nucleated cells. They bind to peptide antigens derived from intracellular proteins (e.g., viral or tumor antigens) and present them to CD8+ cytotoxic T cells, triggering the destruction and elimination of the infected or abnormal cells. 2) Class II HLA Molecules (HLA-DP, HLA-DQ, HLA-DR): Encoded by HLA-DR, -DQ, and -DP loci, these are mainly expressed on professional antigen-presenting cells (APCs), including dendritic cells, macrophages, and B lymphocytes. They present peptide antigens from extracellular sources (e.g., bacterial antigens) to CD4+ helper T cells, which coordinate downstream immune responses such as B cell activation and cytokine secretion. 3) Class III HLA Molecules: This class comprises genes encoding secreted proteins involved in immune regulation, such as complement components (C2, C4), tumor necrosis factor (TNF), and heat shock proteins. Unlike Class I and II, they do not function in antigen presentation but support immune effector mechanisms. HLA Function The biological functions of HLA are central to maintaining immune homeostasis and defending against pathogens. The primary function of HLA molecules is antigen presentation. By displaying fragments of proteins (peptides) on the cell surface, they allow T-cells to continuously scan the body's cellular health. This process is vital for defending against infections, eliminating cancerous cells, mediating organ and tissue transplant rejection, and contributing to autoimmune disorders when the system malfunctions.1) Antigen Presentation: The core function of Class I and II HLA molecules is to present peptide antigens to T cells, enabling the immune system to detect infected, mutated, or foreign cells. 2) Immune Tolerance: During T cell development in the thymus, HLA molecules mediate positive and negative selection, ensuring that mature T cells recognize self-HLA (positive selection) but do not react to self-antigens (negative selection), preventing autoimmunity. 3) Transplant Compatibility: HLA polymorphism is a major barrier to organ and tissue transplantation. Mismatches between donor and recipient HLA molecules trigger alloimmune responses, leading to transplant rejection. 4) Pathogen Resistance and Susceptibility: Specific HLA alleles are associated with increased or decreased susceptibility to infectious diseases (e.g., HLA-B*57:01 confers resistance to HIV progression) and autoimmune disorders (e.g., HLA-DR4 is linked to rheumatoid arthritis). HLA Polymorphism The most striking characteristic of the HLA system is its extreme polymorphism - it is the most polymorphic gene system in the human genome. This means there are hundreds to thousands of different alleles (variants) for each HLA gene within the human population (e.g., over 7,000 alleles for HLA-B). This polymorphism arises from genetic recombination, point mutations, and gene conversion, resulting in extensive diversity in HLA molecule structure. The high degree of polymorphism ensures that the human population as a whole can recognize and respond to a vast array of pathogenic antigens, enhancing species survival. However, it also poses challenges in transplantation, as finding HLA-matched donors is often difficult, especially in diverse populations.HLA Research Hotspots HLA research remains a rapidly advancing and dynamic field with significant implications for medicine and immunology.1) Cancer Immunotherapy (Immuno-oncology): Investigating how specific HLA molecules present tumor neoantigens to T cells, and developing strategies to enhance this process (e.g., HLA-based personalized cancer vaccines, checkpoint inhibitors targeting HLA-T cell interactions). 2) Autoimmune Disease Mechanisms: Identifying certain HLA alleles associated with autoimmune diseases (e.g., Type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and celiac disease) and elucidating how they contribute to the breakdown of immune tolerance. 3) Infectious Disease Susceptibility: Studying HLA-allele specificities for viral, bacterial, and parasitic antigens (like HIV, COVID-19, and malaria) to develop targeted vaccines and understand why some individuals are more resilient to infections. 4) Personalized/Precision Medicine: Integrating HLA typing into personalized treatment plans, such as selecting patients likely to respond to certain immunotherapies based on their HLA profile. 5) Transplant Immunology / Gene & Cell Therapy: Developing techniques for high-resolution HLA typing, predicting transplant rejection risk based on HLA mismatches, and engineered cells (e.g., CAR-T cells) or organoids have compatible HLA profiles to avoid immune rejection. |
|
|
Products & Services Resources | ||
|
Home Products & Services Support About Us Contact Us |
Promotions Flyers Brochures Publications News & Events |
Terms & Conditions Privacy Disclaimers |
Contact Us EMAIL: admin@rgbiotech.com |
||
| © RGBiotech All Rights Reserved. | |||||